Found 15 matching trials
Prioritized Clinical Decision Support (CDS) to Reduce Cardiovascular Risk NA The objective of this project is to develop and implement sophisticated poi...
Show More Location
Multiple Locations
Learn More & Join Trial
Nigerian Breast Cancer Risk-Reduction Study NA The study will be a randomized controlled trial. The aim of the study is to...
Show More Location
Obafemi Awolowo University Teaching Hospital Complex (OAUTHC)
Learn More & Join Trial
Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT PHASE1 The purpose of this study is to find out if a combination of drugs (these a...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
A Patient-oriented Risk Communication Tool to Improve Patient Experience, Knowledge and Outcomes After Elective Surgery N/A Many people have inpatient surgery each day. Most people will have no compl...
Show More Location
The Ottawa Hospital
Learn More & Join Trial
Impact of Systematic Nursing Orientations in the Reduction of Predicted Cardiovascular Risk in Patients With Coronary Artery Disease. NA Evaluate the impact of systematic nursing orientations in the reduction of ...
Show More Location
Eneida Rejane Rabelo
Learn More & Join Trial
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy PHASE2 This is an single arm, open label, interventional phase II trial evaluating...
Show More Status
Active Not Recruiting
Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
BrighT STAR LIBRA: Leveraging Implementation Science for Blood Culture Reduction Approaches NA This study will compare two strategies that target distinct determinants of...
Show More Status
Active Not Recruiting
Location
UCLA Mattel Children's Hospital
Learn More & Join Trial
Influence of Intervention Methodologies on Patient Choice of Therapy NA Few studies have explored how specific formats of effectiveness information...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors PHASE2 The aim of this study was to observe the efficacy and safety of Efbemalenog...
Show More Location
Henan Provincial People's Hospital
Learn More & Join Trial
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene PHASE1 The goal of this clinical research study is to learn if giving genetically ...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial